Fundraising FoxQiming Venture Partners — 2025 Investments
7 investments dated 2025 · listed companies and verified rows first · show all
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Greg Lazar, Ph.D.(Co-Founder and Chief Scientific Officer)Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)in
BoardAlicia Levey(Director)
Co-investorsSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming HealthcareQiming Venture Partners USA
Aureka Biotechnologies is a tech-bio startup that combines high-throughput digital biology data with generative AI to discover protein and antibody therapeutics.
AI & Machine LearningBiotechDeep Tech
Co-investorsDevice of Tomorrow Capital
Stairway Medical develops medical devices and technologies to make procedural sedation safer and simpler, with a focus on preventing airway complications and enabling reliable breathing monitoring.
HardwareHealthtechMedical DevicesStockholm, SE
Co-investorsLU Innovation
Theraheart is a medical device manufacturer developing minimally invasive technologies to treat heart failure patients.
HealthtechMedical DevicesIrvine, US
Wei Gan(Executive Officer, Director)in
BoardSheng Wang(Director)Rani Mahmoudi(Director)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Sany Hydrogen EnergySharpaTOPI Imaging Technology
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.